Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Shirin Khambata‐Ford | Researchclopedia

Back to researchers

Shirin Khambata‐Ford

Daiichi Sankyo (United States)

56

Works

7,257

Citations

19

h-index

22

i10-index

Research Topics

Colorectal Cancer Treatments and Studies Lung Cancer Treatments and Mutations Genetic factors in colorectal cancer

Affiliations

Università Cattolica del Sacro Cuore2018–2018

Ontario Institute for Cancer Research2012–2012

University of Southern California2009–2009

Queen's University Belfast2016–2016

Novartis (Switzerland)2012–2012

Top Works

<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Christos S. Karapetis,Shirin Khambata‐Ford,et al.

20083,575 citations

Gastric Cancer Management and Outcomes

Cancer Treatment and Pharmacology

Expression of Epiregulin and Amphiregulin and <i>K-ras</i> Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab

Shirin Khambata‐Ford,Christopher R. Garrett,et al.

20071,126 citations

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

Wendy De Roock,Derek J. Jonker,et al.

2010746 citations

Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines

Heinz‐Josef Lenz,Eric Van Cutsem,et al.

2006536 citations

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer

Shirin Khambata‐Ford,Christopher Harbison,et al.

2010268 citations

Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study

Manfred Dietel,Н. А. Савелов,et al.

2019156 citations

Responsiveness to Cetuximab without Mutations in<i>EGFR</i>

Zenta Tsuchihashi,Shirin Khambata‐Ford,et al.

2005118 citations

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

Joffre Baker,Debjani Dutta,et al.

2011108 citations

Use of the 22C3 anti–PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms

Marius Ilié,Shirin Khambata‐Ford,et al.

201799 citations